SIBN - SI-BONE, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Santa Clara,
United States
Type: Equity
SIBN price evolution
SIBN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.27 | $53.49 | $110.81 | $22.97 |
| Short term investments | $132.75 | $113.26 | $58.62 | $63 |
| Net receivables | $21.95 | $19.99 | $20.42 | $22.6 |
| Inventory | $20.25 | $22.34 | $20.55 | $17.79 |
| Total current assets | $211.39 | $211.02 | $212.53 | $128.4 |
| Long term investments | ||||
| Property, plant & equipment | $18.71 | $19.52 | $20.95 | $20.3 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $19.03 | $19.86 | $21.29 | $20.68 |
| Total investments | $132.75 | $113.26 | $58.62 | $63 |
| Total assets | $230.43 | $230.88 | $233.82 | $149.08 |
| Current liabilities | ||||
| Accounts payable | $4.59 | $4.42 | $6.16 | $5.33 |
| Deferred revenue | ||||
| Short long term debt | $1.42 | $1.4 | $1.4 | $1.4 |
| Total current liabilities | $23.46 | $19.37 | $18.2 | $16.63 |
| Long term debt | $37.58 | $37.89 | $38.19 | $38.46 |
| Total noncurrent liabilities | $37.59 | $37.91 | $38.22 | $38.49 |
| Total debt | $38.99 | $39.29 | $39.59 | $39.86 |
| Total liabilities | $61.05 | $57.28 | $56.42 | $55.12 |
| Shareholders' equity | ||||
| Retained earnings | -$400.44 | -$389.46 | -$379.44 | -$368.23 |
| Other shareholder equity | $0.34 | $0.36 | $0.3 | $0.3 |
| Total shareholder equity | $169.38 | $173.6 | $177.41 | $93.96 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.27 | $20.72 | $63.42 | $53.58 |
| Short term investments | $132.75 | $76.57 | $83.56 | $142.85 |
| Net receivables | $21.95 | $20.67 | $14.25 | $13.61 |
| Inventory | $20.25 | $17.28 | $11.5 | $5.63 |
| Total current assets | $211.39 | $137.61 | $175.87 | $218.24 |
| Long term investments | ||||
| Property, plant & equipment | $18.71 | $19.57 | $14.24 | $4.53 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $19.03 | $19.94 | $14.64 | $4.9 |
| Total investments | $132.75 | $76.57 | $83.56 | $142.85 |
| Total assets | $230.43 | $157.55 | $190.51 | $223.14 |
| Current liabilities | ||||
| Accounts payable | $4.59 | $6.28 | $3.2 | $3.27 |
| Deferred revenue | ||||
| Short long term debt | $1.42 | $1.39 | $1.34 | |
| Total current liabilities | $23.46 | $21.18 | $16.89 | $13.47 |
| Long term debt | $37.58 | $35.17 | $39.14 | $39.45 |
| Total noncurrent liabilities | $37.59 | $38.07 | $39.2 | $40.31 |
| Total debt | $38.99 | $39.43 | $40.48 | $39.45 |
| Total liabilities | $61.05 | $59.25 | $56.09 | $53.78 |
| Shareholders' equity | ||||
| Retained earnings | -$400.44 | -$357.11 | -$295.85 | -$239.28 |
| Other shareholder equity | $0.34 | $0.23 | $0.35 | $0.52 |
| Total shareholder equity | $169.38 | $98.3 | $134.42 | $169.36 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $38.86 | $34.01 | $33.3 | $32.71 |
| Cost of revenue | $10.18 | $7.04 | $6.32 | $5.92 |
| Gross Profit | $28.68 | $26.97 | $26.99 | $26.78 |
| Operating activities | ||||
| Research & development | $4.16 | $3.92 | $3.66 | $3.29 |
| Selling, general & administrative | $37.02 | $34.22 | $35.29 | $34.79 |
| Total operating expenses | $41.18 | $38.14 | $38.95 | $38.08 |
| Operating income | -$12.51 | -$11.17 | -$11.96 | -$11.29 |
| Income from continuing operations | ||||
| EBIT | -$10.09 | -$9.14 | -$10.36 | -$10.29 |
| Income tax expense | ||||
| Interest expense | $0.89 | $0.88 | $0.85 | $0.84 |
| Net income | ||||
| Net income | -$10.98 | -$10.02 | -$11.21 | -$11.13 |
| Income (for common shares) | -$10.98 | -$10.02 | -$11.21 | -$11.13 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $138.89 | $106.41 | $90.15 | $73.39 |
| Cost of revenue | $29.47 | $15.71 | $10.43 | $8.9 |
| Gross Profit | $109.42 | $90.7 | $79.72 | $64.48 |
| Operating activities | ||||
| Research & development | $15.03 | $13.63 | $12.44 | $9.46 |
| Selling, general & administrative | $141.32 | $136.69 | $118.95 | $93.59 |
| Total operating expenses | $156.35 | $150.31 | $131.39 | $103.05 |
| Operating income | -$46.93 | -$59.61 | -$51.67 | -$38.57 |
| Income from continuing operations | ||||
| EBIT | -$39.87 | -$58.44 | -$51.21 | -$37.6 |
| Income tax expense | ||||
| Interest expense | $3.46 | $2.82 | $5.37 | $6.1 |
| Net income | ||||
| Net income | -$43.34 | -$61.26 | -$56.57 | -$43.7 |
| Income (for common shares) | -$43.34 | -$61.26 | -$56.57 | -$43.7 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$10.98 | -$10.02 | -$11.21 | -$11.13 |
| Operating activities | ||||
| Depreciation | $1.57 | $1.53 | $1.24 | $1.09 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.94 | $5.93 | $6 | $6.19 |
| Total cash flows from operations | -$2.3 | -$2.07 | -$3.59 | -$10.75 |
| Investing activities | ||||
| Capital expenditures | -$1.09 | -$1.41 | -$2.71 | -$2.58 |
| Investments | -$17.82 | -$53.46 | $5 | $14.28 |
| Total cash flows from investing | -$18.91 | -$54.87 | $2.28 | $11.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.84 | -$0.24 | $89.12 | $0.52 |
| Net borrowings | $0.69 | |||
| Total cash flows from financing | $0.84 | -$0.24 | $89.12 | $1.21 |
| Effect of exchange rate | $0.15 | -$0.14 | $0.03 | $0.1 |
| Change in cash and equivalents | -$20.22 | -$57.32 | $87.85 | $2.25 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$43.34 | -$61.26 | -$56.57 | -$43.7 |
| Operating activities | ||||
| Depreciation | $5.43 | $3.45 | $2.09 | $1.13 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $24.06 | $23.06 | $16.87 | $11.93 |
| Total cash flows from operations | -$18.71 | -$41.66 | -$39.53 | -$30.66 |
| Investing activities | ||||
| Capital expenditures | -$7.8 | -$9.51 | -$6.39 | -$2.56 |
| Investments | -$52 | $6.69 | $57.97 | -$60.35 |
| Total cash flows from investing | -$59.8 | -$2.81 | $51.58 | -$62.92 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $90.25 | $2.2 | $4.91 | $137.99 |
| Net borrowings | $0.69 | -$6.62 | -$1.59 | |
| Total cash flows from financing | $90.93 | $2.2 | -$1.71 | $136.4 |
| Effect of exchange rate | $0.13 | -$0.43 | -$0.5 | $0.32 |
| Change in cash and equivalents | $12.55 | -$42.7 | $9.84 | $43.15 |
News
Fundamentals
| Market cap | $616.83M |
|---|---|
| Enterprise value | $622.55M |
| Shares outstanding | 40.50M |
| Revenue | $138.89M |
|---|---|
| EBITDA | -$34.45M |
| EBIT | -$39.88M |
| Net Income | -$43.34M |
| Revenue Q/Q | 21.61% |
| Revenue Y/Y | 30.52% |
| P/E ratio | -14.23 |
|---|---|
| EV/Sales | 4.48 |
| EV/EBITDA | -18.07 |
| EV/EBIT | -15.61 |
| P/S ratio | 4.44 |
| P/B ratio | 3.65 |
| Book/Share | 4.17 |
| Cash/Share | 0.82 |
| EPS | -$1.07 |
|---|---|
| ROA | -20.53% |
| ROE | -28.22% |
| Debt/Equity | 0.36 |
|---|---|
| Net debt/EBITDA | -0.81 |
| Current ratio | 9.01 |
| Quick ratio | 8.15 |